NMR Nomura
Nomura earnings company data as of 3:58 PM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 28 Oct | EPS | 0.20 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by NMR's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $3,899 bought by 3 insiders
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Masahiro Ishizuka DirectorBuy$1,917 238 shares at $8.05 +244% to stakeTraded Mar 25 Filed Mar 27
-
Yukiko Ozaki See RemarksBuy$64 8 shares at $8.05 +15% to stakeTraded Mar 25 Filed Mar 26
Also filed in the last 12 months, not counted as buying or selling: 37 stock grants, 26 option exercises, 16 share withholdings for taxes, and 10 sales back to the company.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc | |
| 424B2 | PRICING SUPPLEMENT | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.